These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25517948)

  • 1. Fibrosing cholestatic hepatitis C after hematopoietic cell transplantation: report of 3 fatal cases.
    Evans AT; Loeb KR; Shulman HM; Hassan S; Qiu WC; Hockenbery DM; Ioannou GN; Chauncey TR; Gretch DR; McDonald GB
    Am J Surg Pathol; 2015 Feb; 39(2):212-20. PubMed ID: 25517948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrosing cholestatic hepatitis in hepatitis C virus-infected renal transplant recipients.
    Muñoz De Bustillo E; Ibarrola C; Colina F; Castellano G; Fuertes A; Andrés A; Aguado JM; Rodicio JL; Morales JM
    J Am Soc Nephrol; 1998 Jun; 9(6):1109-13. PubMed ID: 9621297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after liver transplantation.
    Kornberg A; Küpper B; Tannapfel A; Hommann M; Scheele J
    Int Immunopharmacol; 2005 Jan; 5(1):107-15. PubMed ID: 15589468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholestatic hepatitis C following liver transplantation: an outcome-based histological definition, clinical predictors, and prognosis.
    Verna EC; Abdelmessih R; Salomao MA; Lefkowitch J; Moreira RK; Brown RS
    Liver Transpl; 2013 Jan; 19(1):78-88. PubMed ID: 23081888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductular reaction and hepatocyte ballooning identify patients with fibrosing cholestatic hepatitits after liver transplantation.
    Llovet LP; Sciarrone S; Rodríguez-Tajes S; Montironi C; Mescoli C; Rugge M; Crespo G; Burra P; Forns X; Diaz A; Londoño MC
    Gastroenterol Hepatol; 2020 Jan; 43(1):14-21. PubMed ID: 31495536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: is azathioprine a contributory factor?
    Delgado J; Muñoz de Bustillo E; Ibarrola C; Colina F; Morales JM; Rodriguez E; Aguado JM; Fuertes A; Gomez MA
    J Heart Lung Transplant; 1999 Jun; 18(6):607-10. PubMed ID: 10395359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.
    Jain A; Kashyap R; Demetris AJ; Eghstesad B; Pokharna R; Fung JJ
    Liver Transpl; 2002 Jan; 8(1):40-6. PubMed ID: 11799484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrosing cholestatic hepatitis after successful interferon and ribavirin therapy for recurrent hepatitis C post living related liver transplantation: a case report.
    Yamamoto T; Tanaka S; Uenishi T; Kanazawa A; Kubo S; Hirohashi K
    Osaka City Med J; 2014 Dec; 60(2):95-100. PubMed ID: 25803885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation.
    Nelson DR; Soldevila-Pico C; Reed A; Abdelmalek MF; Hemming AW; Van der Werf WJ; Howard R; Davis GL
    Liver Transpl; 2001 Dec; 7(12):1064-70. PubMed ID: 11753908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperbilirubinemia and cholestatic liver injury in hepatitis C-infected liver transplant recipients.
    Cotler SJ; Taylor SL; Gretch DR; Bronner MP; Rizk R; Perkins JD; Carithers RL
    Am J Gastroenterol; 2000 Mar; 95(3):753-9. PubMed ID: 10710070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrosing cholestatic hepatitis-like syndrome in hepatitis B virus-negative and hepatitis C virus-negative renal transplant recipients.
    Muñoz de Bustillo E; Benito A; Colina F; Andrés A; Domínguez-Gil B; Muñoz MA; Rodicio JL; Morales JM
    Am J Kidney Dis; 2001 Sep; 38(3):640-5. PubMed ID: 11532698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrosing cholestatic hepatitis: a report of three cases.
    Lee HK; Yoon GS; Min KS; Jung YW; Lee YS; Suh DJ; Yu E
    J Korean Med Sci; 2000 Feb; 15(1):111-4. PubMed ID: 10719821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrosing cholestatic hepatitis after living related-donor renal transplantation.
    Waguri N; Ichida T; Fujimaki R; Ishikawa T; Nomoto M; Asakura H; Nakamaru T; Saitoh A; Arakawa M; Saitoh K; Takahashi K
    J Gastroenterol Hepatol; 1998 Nov; 13(11):1133-7. PubMed ID: 9870801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation.
    Chen CH; Chen PJ; Chu JS; Yeh KH; Lai MY; Chen DS
    Gastroenterology; 1994 Nov; 107(5):1514-8. PubMed ID: 7926515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosing cholestatic hepatitis-like syndrome in a hepatitis B virus and hepatitis C virus-negative renal transplant recipient: a case report with autopsy findings.
    Duseja A; Nada R; Kalra N; Acharya SK; Minz M; Joshi K; Chawla Y
    Trop Gastroenterol; 2003; 24(1):31-4. PubMed ID: 12974214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis.
    Davies SE; Portmann BC; O'Grady JG; Aldis PM; Chaggar K; Alexander GJ; Williams R
    Hepatology; 1991 Jan; 13(1):150-7. PubMed ID: 1988336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibrosing cholestatic hepatitis--disease not only of transplanted patients. A report of eight cases].
    Honsová E; Sperl J
    Cesk Patol; 2011 Apr; 47(2):55-8. PubMed ID: 21604436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fatal fibrosing cholestatic hepatitis following renal transplantation].
    Sprengers D; van Gelder T; Zondervan PE; Niesters HG; Janssen HL; de Man RA
    Ned Tijdschr Geneeskd; 2002 Jul; 146(29):1380-4. PubMed ID: 12162178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of antiviral effect of a short course of mycophenolate mofetil in patients with chronic hepatitis C virus infection.
    Firpi RJ; Nelson DR; Davis GL
    Liver Transpl; 2003 Jan; 9(1):57-61. PubMed ID: 12514774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.